Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-EGFR and anti-ZnO IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can be used in immunoassay of Head and neck cancer; Non-small cell lung cancer (NSCLC); Gastric cancer; Lung cancer; Colorectal cancer (CRC); Solid tumors.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scIgG) (SCIGG-158). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS